Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer
- Citation:
- JAMA Oncol vol 9 (4) 490-499
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3618
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- GSK
- Grants:
- U10CA180821, U10CA180882, U24CA196171, R01CA229409, UG1CA233180, UG1CA233333, UG1CA233373, P50CA58223
- Corr. Author:
- Authors:
- Aranzazu Fernandez-Martinez Tomás Pascual Baljit Singh Paolo Nuciforo Naim U. Rashid Karla V. Ballman Jordan D. Campbell Katherine A. Hoadley Patricia A. Spears Laia Pare Fara Brasó-Maristany Nuria Chic Ian Krop Ann Partridge Javier Cortés Antonio Llombart-Cussac Aleix Prat Charles M. Perou Lisa A. Carey
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007
- Study
- Alliance-A152117
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-40601, PAMELA
- Phases:
- N/A, 2, 3
- Keywords:
- Research, Research, Original Investigation, Online First, Comments